Kalshi to launch betting on drug trial outcomes and FDA rulings
Prediction market platform Kalshi announced plans to offer bets on the results of clinical drug trials and decisions from the U.S. Food and Drug Administration. This move raises ethical questions about commodifying health data and could undermine public trust in medical research.